Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2011 3
2012 2
2013 4
2014 1
2015 6
2016 6
2017 6
2018 6
2019 4
2020 7
2021 6
2022 2
2023 3
2024 4
2025 4
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With Human Immunodeficiency Virus Type 1: First Results From the ANRS-MIE CARLAPOP Study.
Néant N, Lê MP, Bouchet S, Lagoutte-Renosi J, Grégoire M, Parant F, Venisse N, Lalanne S, Lemaitre F, Muret P, Renou Q, Destere A, Gandia P, Flandre P, Peytavin G, Solas C; ANRS-MIE-CARLAPOP Study Group. Néant N, et al. Clin Infect Dis. 2025 Aug 18:ciaf385. doi: 10.1093/cid/ciaf385. Online ahead of print. Clin Infect Dis. 2025. PMID: 40820336
HIV infection and care pathway: From guidelines to clinical practice.
Poizot-Martin I, Obry-Roguet V, Zaegel-Faucher O, Lions C, Cano C, Ivanova A, Ritleng A, Debreux C, Bregigeon S. Poizot-Martin I, et al. Among authors: obry roguet v. Med Mal Infect. 2019 Feb;49(1):23-33. doi: 10.1016/j.medmal.2018.07.005. Epub 2018 Sep 5. Med Mal Infect. 2019. PMID: 30195462
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
Lemaitre F, Lagoutte-Renosi J, Gagnieu MC, Parant F, Venisse N, Grégoire M, Bouchet S, Garraffo R, Lê MP, Muret P, Comets E, Solas C, Peytavin G; ANRS-MIE-BIRIDER Study group on behalf of the Clinical Pharmacology Group of ANRS-MIE AC43. Lemaitre F, et al. Br J Clin Pharmacol. 2024 Jan;90(1):264-273. doi: 10.1111/bcp.15890. Epub 2023 Sep 18. Br J Clin Pharmacol. 2024. PMID: 37602480 Free article.
54 results